Lorinda Chung Selected Research

Lorinda Chung Research Topics

Disease

34	Systemic Scleroderma (Systemic Sclerosis) 05/2022 - 05/2006
14	Dermatomyositis (Dermatopolymyositis) 07/2022 - 06/2007
14	Pulmonary Arterial Hypertension 01/2022 - 09/2006
11	Calcinosis 02/2022 - 06/2014
9	Inflammation (Inflammations) 05/2022 - 06/2011
9	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2021 - 07/2011
8	Fibrosis (Cirrhosis) 05/2022 - 09/2006
7	Connective Tissue Diseases (Connective Tissue Disease) 02/2022 - 12/2010
6	Pulmonary Hypertension 01/2021 - 06/2007
6	Neoplasms (Cancer) 01/2021 - 06/2007
6	digital ulcers 11/2018 - 05/2006
5	Diffuse Scleroderma (Progressive Systemic Sclerosis) 12/2020 - 06/2015
5	Ulcer 12/2015 - 05/2006
4	Ischemia 01/2022 - 01/2010
4	Wounds and Injuries (Trauma) 01/2022 - 06/2007
4	Infections 12/2020 - 06/2007
4	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 04/2004
4	Skin Diseases (Skin Disease) 01/2018 - 06/2007
4	Pain (Aches) 12/2015 - 06/2007
3	Calcinosis Cutis 02/2022 - 11/2015
3	Melanoma (Melanoma, Malignant) 02/2022 - 07/2011
3	Myositis (Idiopathic Inflammatory Myopathies) 06/2020 - 09/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 06/2014
3	Telangiectasis (Telangiectasia) 06/2014 - 11/2013
3	Raynaud Disease (Raynaud's Disease) 06/2014 - 06/2007
3	Arthritis (Polyarthritis) 07/2011 - 06/2007
2	Hypoxia (Hypoxemia) 02/2022 - 11/2018
2	Polymyositis 02/2022 - 04/2004
2	Sclerosis 02/2022 - 02/2009
2	Pericardial Effusion 01/2019 - 12/2010
2	Dyspnea (Shortness of Breath) 01/2019 - 03/2013
2	Acro-Osteolysis (Acroosteolysis) 11/2018 - 11/2015
2	Fatigue 01/2018 - 01/2016
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2018 - 04/2008
2	Headache (Headaches) 01/2016 - 03/2009
2	Mixed Connective Tissue Disease (MCTD) 12/2013 - 12/2010
2	Hyperuricemia 07/2012 - 04/2011
1	Muscular Diseases (Myopathy) 02/2022
1	Diarrhea 03/2021
1	Gastric Antral Vascular Ectasia (Watermelon Stomach) 10/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Anemia 01/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Rupture 01/2018
1	Deglutition Disorders (Dysphagia) 12/2017
1	Myalgia 12/2017
1	Edema (Dropsy) 12/2017

Drug/Important Bio-Agent (IBA)

12	AutoantibodiesIBA 02/2022 - 06/2011
10	AntibodiesIBA 10/2020 - 04/2004
7	CalciumIBA 02/2022 - 07/2014
4	Rituximab (Mabthera)FDA Link 01/2021 - 11/2006
3	CytokinesIBA 05/2022 - 06/2011
3	ametantrone (HAQ)IBA 01/2022 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2017
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2021 - 12/2010
3	Abatacept (Orencia)FDA Link 12/2020 - 06/2015
3	tocilizumab (atlizumab)FDA Link 01/2018 - 06/2016
3	Carbon MonoxideIBA 08/2014 - 12/2010
3	Endothelin Receptor AntagonistsIBA 08/2014 - 06/2007
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2020
2	Phosphates (Orthophosphate)IBA 02/2022 - 06/2020
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2022 - 01/2010
2	treprostinil FDA Link 01/2022 - 05/2006
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 06/2007
2	ChromatinIBA 12/2020 - 11/2020
2	RNA Polymerase IIIIBA 10/2020 - 12/2016
2	CollagenIBA 04/2020 - 01/2013
2	anticentromere antibodyIBA 11/2018 - 11/2015
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2017 - 12/2010
2	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 12/2014 - 12/2010
2	Uric Acid (Urate)IBA 07/2012 - 04/2011
1	Oncostatin MIBA 05/2022
1	Monoclonal AntibodiesIBA 05/2022
1	Biological ProductsIBA 05/2022
1	carboapatiteIBA 02/2022
1	MineralsIBA 02/2022
1	Durapatite (Hydroxylapatite)IBA 02/2022
1	Calcium CompoundsIBA 01/2022
1	sodium thiosulfate FDA Link 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	Phosphorus (Red Phosphorus)IBA 01/2022
1	Vasodilator Agents (Vasodilators)IBA 01/2022
1	nintedanibIBA 03/2021
1	Pharmaceutical PreparationsIBA 02/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	SaltsIBA 06/2020
1	lenabasum (ajulemic acid)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018
1	nuclear matrix protein 2IBA 12/2017
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2017

Therapy/Procedure

15	Therapeutics 01/2022 - 05/2006
2	Length of Stay 01/2018 - 04/2008
2	Sympathectomy (Sympathectomies) 12/2015 - 09/2015
1	Immunomodulation 07/2022
1	Activities of Daily Living (ADL) 01/2020